In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
AUTOR(ES)
Katsu, K
RESUMO
E-0702 is an antipseudomonal cephalosporin derivative which has a broad spectrum of antibacterial activity against clinical isolates of gram-positive and gram-negative bacteria. Its in vitro antibacterial activities were less than those of cefoperazone and cefotaxime against Staphylococcus aureus and Staphylococcus epidermidis, but were significantly high against gram-negative bacteria including the Pseudomonas group. It was most characteristic that E-0702 showed high antibacterial activity against Pseudomonas aeruginosa. E-0702 was relatively stable to inactivation by plasmid-mediated penicillinases and cephalosporinases produced by gram-negative bacteria.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=183706Documentos Relacionados
- In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.
- In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
- In vitro antibacterial activity of ME1207, a new oral cephalosporin.
- In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
- In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
